Amgen enters into strategic collaboration with BeiGene to expand oncology presence in China

This article was originally published here

BeiGene is a research-based, oncology-focused biotechnology company with an established and highly experienced team in China, including a 700-person commercial organization and a 600-person clinical development organization. “This

The post Amgen enters into strategic collaboration with BeiGene to expand oncology presence in China appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply